Manulife (Manufacturers Life Insurance)’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$111K Sell
13,368
-1,587
-11% -$14.3K ﹤0.01% 2604
2025
Q4
$144K Sell
14,955
-1,808
-11% -$17.1K ﹤0.01% 2633
2025
Q3
$159K Sell
16,763
-1,415
-8% -$11.9K ﹤0.01% 2655
2025
Q2
$136K Buy
18,178
+1,557
+9% +$9.66K ﹤0.01% 2698
2025
Q1
$101K Sell
16,621
-297
-2% -$2.06K ﹤0.01% 2689
2024
Q4
$132K Sell
16,918
-178
-1% -$1.33K ﹤0.01% 2760
2024
Q3
$139K Sell
17,096
-587
-3% -$4.8K ﹤0.01% 2776
2024
Q2
$122K Buy
17,683
+1,534
+9% +$20.7K ﹤0.01% 2779
2024
Q1
$286K Sell
16,149
-591
-4% -$9.36K ﹤0.01% 2418
2023
Q4
$259K Sell
16,740
-497
-3% -$6.49K ﹤0.01% 2479
2023
Q3
$236K Hold
17,237
﹤0.01% 2496
2023
Q2
$297K Sell
17,237
-16
-0.1% -$327 ﹤0.01% 2372
2023
Q1
$414K Sell
17,253
-627
-4% -$13.6K ﹤0.01% 2124
2022
Q4
$310K Buy
17,880
+77
+0.4% +$1.62K ﹤0.01% 2286
2022
Q3
$434K Sell
17,803
-375
-2% -$12.9K ﹤0.01% 2067
2022
Q2
$563K Buy
18,178
+1,280
+8% +$34.1K ﹤0.01% 1974
2022
Q1
$590K Sell
16,898
-3,766
-18% -$142K ﹤0.01% 2094
2021
Q4
$1.22K Sell
20,664
-200
-1% -$13.8K ﹤0.01% 1711
2021
Q3
$1.39M Sell
20,864
-2,000
-9% -$123K ﹤0.01% 1646
2021
Q2
$1.44M Buy
22,864
+491
+2% +$27.6K ﹤0.01% 1769
2021
Q1
$1.16M Buy
22,373
+1,448
+7% +$88.1K ﹤0.01% 1798
2020
Q4
$918K Buy
20,925
+1,050
+5% +$50K ﹤0.01% 1873
2020
Q3
$942K Sell
19,875
-247
-1% -$10K ﹤0.01% 1682
2020
Q2
$582K Sell
20,122
-127
-0.6% -$2.83K ﹤0.01% 1882
2020
Q1
$346K Buy
20,249
+1,168
+6% +$20.5K ﹤0.01% 2015
2019
Q4
$314K Buy
19,081
+387
+2% +$5.76K ﹤0.01% 2311
2019
Q3
$300K Buy
18,694
+1,065
+6% +$21.3K ﹤0.01% 2321
2019
Q2
$323K Buy
17,629
+7,187
+69% +$114K ﹤0.01% 2318
2019
Q1
$135K Buy
+10,442
New +$113K ﹤0.01% 2528
2018
Q4
Sell
-10,179
Closed -$130K 2555
2018
Q3
$130K Sell
10,179
-9,716
-49% -$139K ﹤0.01% 2866
2018
Q2
$314K Buy
19,895
+18,873
+1,847% +$201K ﹤0.01% 2745
2018
Q1
$9K Buy
1,022
+128
+14% +$1.13K ﹤0.01% 3941
2017
Q4
$8K Buy
+894
New +$7.01K ﹤0.01% 4033

Other funds holding CYRX